Biotechnology Market Size, Share & Trends Analysis By Technology (DNA Sequencing, Fermentation), By Application (Health, Bioinformatics), By Region (North America, EU, APAC), And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Research Assumptions
• 1.2 Research Methodology
• 1.3 Information Procurement
• 1.4 Information or Data Analysis
• 1.5 Market Formulation and Validation
• 1.6 Global Market: CAGR Calculation
• 1.7 Objectives
  • 1.7.1 Objective 1
  • 1.7.2 Objective 2
• 1.8 Revenue Modeling: Post-COVID-19 Market Scenario
  • 1.8.1 Present market dynamics assessment: Company evaluation
  • 1.8.2 Market dynamics assessment: future projections
  • 1.8.3 Top 20 operational entities: Company revenue & market value analysis
    • 1.8.3.1 Part A
    • 1.8.3.2 Part B
    • 1.8.3.3 Part C

Chapter 2 Executive Summary

• 2.1 Market Snapshot

Chapter 3 Market Variables, Trends, and Scope

• 3.1 Market Trends and Outlook
• 3.2 Market Segmentation and Scope
• 3.3 Market Dynamics
  • 3.3.1 Market driver analysis
    • 3.3.1.1 Presence of favorable government initiatives
    • 3.3.1.2 Rising demand for agro-based products
    • 3.3.1.3 Growing demand for synthetic biology
    • 3.3.1.4 Declining prices of DNA sequencing
    • 3.3.1.5 Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
  • 3.3.2 Market restraint analysis
    • 3.3.2.1 Ethical & legal limitations
    • 3.3.2.2 Risks associated with GM organisms and crops
    • 3.3.2.3 Challenges associated with NGS implementation
• 3.4 Penetration and Growth Prospect Mapping for Technology, 2021
• 3.5 Market Share Analysis, 2021
• 3.6 Business Environment Analysis
  • 3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
  • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Biotechnology Categorization: Application Estimates & Trend Analysis

• 4.1 Biotechnology Market: Application Movement Analysis
• 4.2 Health
  • 4.2.1 Pre-COVID Segment Scenario
  • 4.2.2 Post-COVID Segment Scenario
  • 4.2.3 Global health Biotechnology market, 2018 - 2030 (USD Billion)
• 4.3 Food & Agriculture
  • 4.3.1 Pre-COVID Segment Scenario
  • 4.3.2 Post-COVID Segment Scenario
  • 4.3.3 Global Food & Agriculture Biotechnology market, 2018 - 2030 (USD Billion)
• 4.4 Natural Resources & Environment
  • 4.4.1 Pre-COVID Segment Scenario
  • 4.4.2 Post-COVID Segment Scenario
  • 4.4.3 Global Natural resources & environment Biotechnology market, 2018 - 2030 (USD Billion)
• 4.5 Industrial Processing
  • 4.5.1 Pre-COVID Segment Scenario
  • 4.5.2 Post-COVID Segment Scenario
  • 4.5.3 Global Industrial processing Biotechnology market, 2018 - 2030 (USD Billion)
• 4.6 Bioinformatics
  • 4.6.1 Pre-COVID Segment Scenario
  • 4.6.2 Post-COVID Segment Scenario
  • 4.6.3 Global Bioinformatics Biotechnology market, 2018 - 2030 (USD Billion)
• 4.7 Other Applications
  • 4.7.1 Global Biotechnology market for applications, 2018 - 2030 (USD Billion)

Chapter 5 Biotechnology Market Categorization: Technology Estimates & Trend Analysis

• 5.1 Biotechnology Market: Technology Movement Analysis
• 5.2 DNA Sequencing
  • 5.2.1 Pre-COVID Segment Scenario
  • 5.2.2 Post-COVID Segment Scenario
  • 5.2.3 Global Biotechnology market for DNA Sequencing, 2018 - 2030 (USD Billion)
• 5.3 Nanobiotechnology
  • 5.3.1 Pre-COVID Segment Scenario
  • 5.3.2 Post-COVID Segment Scenario
  • 5.3.3 Global Biotechnology market for Nanobiotechnology, 2018 - 2030 (USD Billion)
• 5.4 Tissue Engineering & Regeneration
  • 5.4.1 Pre-COVID Segment Scenario
  • 5.4.2 Post-COVID Segment Scenario
  • 5.4.3 Global Biotechnology market for Tissue engineering and regeneration, 2018 - 2030 (USD Billion)
• 5.5 Fermentation
  • 5.5.1 Pre-COVID Segment Scenario
  • 5.5.2 Post-COVID Segment Scenario
  • 5.5.3 Biopharmaceutical Manufacturing
  • 5.5.4 Biopharmaceutical & Biotechnology Research
  • 5.5.5 Others
  • 5.5.6 Global Biotechnology market for Fermentation, 2018 - 2030 (USD Billion)
• 5.6 Cell-based Assays
  • 5.6.1 Pre-COVID Segment Scenario
  • 5.6.2 Post-COVID Segment Scenario
  • 5.6.3 Global Biotechnology market for Cell-based assays, 2018 - 2030 (USD Billion)
• 5.7 PCR Technology
  • 5.7.1 Pre-COVID Segment Scenario
  • 5.7.2 Post-COVID Segment Scenario
  • 5.7.3 Global Biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
• 5.8 Chromatography
  • 5.8.1 Pre-COVID Segment Scenario
  • 5.8.2 Post-COVID Segment Scenario
  • 5.8.3 Global Biotechnology market for Chromatography, 2018 - 2030 (USD Billion)
• 5.9 Other Technologies
  • 5.9.1 Pre-COVID Segment Scenario
  • 5.9.2 Post-COVID Segment Scenario
  • 5.9.3 Global Biotechnology market for Other technologies, 2018 - 2030 (USD Billion)

Chapter 6 Biotechnology Market Categorization: Regional Estimates & Trend Analysis, by Application & Technology

• 6.1 Biotechnology Share by Regional, 2021 & 2030
• 6.2 North America
  • 6.2.1 U.S.
  • 6.2.2 Canada
• 6.3 Europe
  • 6.3.1Germany
  • 6.3.2 U.K.
  • 6.3.3 France
  • 6.3.4 Italy
  • 6.3.5 Spain
• 6.4 Asia-Pacific
  • 6.4.1 Japan
  • 6.4.2 China
  • 6.4.3 India
  • 6.4.4 South Korea
  • 6.4.5 Australia
• 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Mexico
• 6.6 Middle East and Africa (MEA)
  • 6.6.1 South Africa
  • 6.6.2 Saudi Arabia

Chapter 7 Competitive Landscape

• 7.1 Strategy Framework
• 7.2 Company Profiles
  • 7.2.1 AstraZeneca
    • 7.2.1.1 Company Overview
    • 7.2.1.2 Financial Performance
    • 7.2.1.3 Product Benchmarking
    • 7.2.1.4 Strategic Initiatives
  • 7.2.2 Gilead Sciences Inc.
    • 7.2.2.1 Company Overview
    • 7.2.2.2 Financial Performance
    • 7.2.2.3 Product Benchmarking
    • 7.2.2.4 Strategic Initiatives
  • 7.2.3 Bristol-Myers Squibb
    • 7.2.3.1 Company Overview
    • 7.2.3.1.1 Celgene Corporation
    • 7.2.3.2 Financial Performance
    • 7.2.3.3 Product Benchmarking
    • 7.2.3.4 Strategic Initiatives
  • 7.2.4 Biogen
    • 7.2.4.1 Company Overview
    • 7.2.4.2 Financial Performance
    • 7.2.4.3 Product Benchmarking
    • 7.2.4.4 Strategic Initiatives
  • 7.2.5 Abbott Laboratories
    • 7.2.5.1 Company Overview
    • 7.2.5.2 Financial Performance
    • 7.2.5.3 Product Benchmarking
    • 7.2.5.4 Strategic Initiatives
  • 7.2.6 Amgen Inc.
    • 7.2.6.1 Company Overview
    • 7.2.6.2 Financial Performance
    • 7.2.6.3 Product Benchmarking
    • 7.2.6.4 Strategic Initiatives
  • 7.2.7 Novo Nordisk A/S
    • 7.2.7.1 Company Overview
    • 7.2.7.2 Financial Performance
    • 7.2.7.3 Product Benchmarking
    • 7.2.7.4 Strategic Initiatives
  • 7.2.8 Merck KGaA
    • 7.2.8.1 Company Overview
    • 7.2.8.2 Financial Performance
    • 7.2.8.3 Product Benchmarking
    • 7.2.8.4 Strategic Initiatives
  • 7.2.9 Johnson & Johnson Services
    • 7.2.9.1 Company Overview
    • 7.2.9.2 Financial Performance
    • 7.2.9.3 Product Benchmarking
    • 7.2.9.4 Strategic Initiatives
  • 7.2.10 Novartis AG
    • 7.2.10.1 Company Overview
    • 7.2.10.2 Financial Performance
    • 7.2.10.3 Product Benchmarking
    • 7.2.10.4 Strategic Initiatives
  • 7.2.11 Sanofi
    • 7.2.11.1 Company overview
    • 7.2.11.1.1 Genzyme
    • 7.2.11.2 Financial Performance
    • 7.2.11.3 Product Benchmarking
    • 7.2.11.4 Strategic Initiatives
  • 7.2.12 F. Hoffmann-La Roche Ltd.
    • 7.2.12.1 Company Overview
    • 7.2.12.2 Financial Performance
    • 7.2.12.3 Product Benchmarking
    • 7.2.12.4 Strategic Initiatives
  • 7.2.13 Pfizer Inc.
    • 7.2.13.1 Company overview
    • 7.2.13.2 Financial Performance
    • 7.2.13.3 Product Benchmarking
    • 7.2.13.4 Strategic Initiatives
  • 7.2.14 Lonza
    • 7.2.14.1 Company Overview
    • 7.2.14.2 Financial Performance
    • 7.2.14.3 Product Benchmarking
    • 7.2.14.4 Strategic Initiatives

List of Tables

• Table 1 Healthcare expenditure levels, 2018 - 2022
• Table 2 Various approaches in regenerative medicine for dermatological use
• Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions
• Table 4 North America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 5 North America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 6 U.S. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 8 Canada biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 9 Canada biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 10 Europe biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 11 Europe biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 12 Germany biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 13 Germany biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 14 U.K. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 16 France biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 17 France biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 18 Italy biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 19 Italy biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 20 Spain biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 21 Spain biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 24 Japan biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 25 Japan biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 26 Main monographs published in China
• Table 27 China biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 28 China biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 29 India biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 30 India biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 31 South Korea biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 33 Australia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 34 Australia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 35 Latin America: Current initiatives and opportunities
• Table 36 Latin America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 38 Brazil biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 40 Mexico biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 42 MEA biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 43 MEA biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 44 South Africa biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
• Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
• Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion) 
• Table 48List of companies evaluated for revenue modeling: Post-COVID market scenario
• Table 49 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
• Table 50 NIH common fund awards for biomedical research
• Table 51 Business grants for life science and biotech in Canada
• Table 52 Applications of bioinformatics tools
• Table 53 Types of cell-based assays and methods of quantification

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Top 10 companies: Market revenue analysis, 2021 (USD Billion)
• Fig. 9 Top 10 companies: Market capital analysis, 2021 (USD Billion)
• Fig. 10 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
• Fig. 11 Market summary, 2021 (USD Billion)
• Fig. 12 Market trends & outlook
• Fig. 13 Market segmentation and scope
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Global financings for regenerative medicine, 2018
• Fig. 16 DNA sequencing: Cost per MB, 2010 - August 2020
• Fig. 17 Cost of per human genome, 2010 - August 2020
• Fig. 18 Market restraint relevance analysis (Current & future impact)
• Fig. 19 Side effects of GM foods
• Fig. 20 Bottlenecks associated with implementation of NGS
• Fig. 21 Penetration and growth prospect mapping for technology, 2021
• Fig. 22 Company market share analysis, 2021
• Fig. 23 SWOT Analysis, By Factor (Political & legal Economic and technological)
• Fig. 24 Porter's Five Forces Analysis
• Fig. 25 Biotechnology market: Application outlook key takeaways
• Fig. 26 Biotechnology market: Application movement analysis
• Fig. 27 Advantages of biotechnology
• Fig. 28 Gene therapy clinical trials number as of February 10, 2021
• Fig. 29 Global health biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 30 Adoption of GM crops by region (millions of hectares)
• Fig. 31 Trait enhancement in plants & crops through recombinant DNA technology
• Fig. 32 Global food & agriculture biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 33 Global natural resources & environment biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 34 Global industrial processing biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 35 Global bioinformatics biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 36 Global biotechnology market for other applications, 2018 - 2030 (USD Billion)
• Fig. 37 Biotechnology market: Technology outlook key takeaways
• Fig. 38 Biotechnology market: Technology movement analysis
• Fig. 39 Matrix of classification of the first, second, and third generation sequencing based on sequencing chemistry
• Fig. 40 Global biotechnology market for DNA sequencing, 2018 - 2030 (USD Billion)
• Fig. 41 Breakdown of nanomedicine products in phase III by therapeutic areas
• Fig. 42 Types of therapeutic nanoparticles
• Fig. 43 Global biotechnology market for nanobiotechnology, 2018 - 2030 (USD Billion)
• Fig. 44 Global biotechnology market for tissue engineering and regeneration, 2018 - 2030 (USD Billion)
• Fig. 45 Benefits of fermented food
• Fig. 46 Global biotechnology market for fermentation, 2018 - 2030 (USD Billion)
• Fig. 47 Global biotechnology market for cell-based assays, 2018 - 2030 (USD Billion)
• Fig. 48 Global biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
• Fig. 49 Global biotechnology market for chromatography, 2018 - 2030 (USD Billion)
• Fig. 50 Global biotechnology market for other technologies, 2018 - 2030 (USD Billion)
• Fig. 51 Regional marketplace: Key takeaway
• Fig. 52 Biotechnology regional outlook, 2021 & 2030
• Fig. 53 North America biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 54 U.S. biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 55 Canada biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 56 Europe biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 57 Germany biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 58 U.K. biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 59 France biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 60 Italy biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 61 Spain biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 62 Asia-Pacific biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 63 Japan biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 64 China biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 65 India biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 66 South Korea biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 67 Australia biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 68 Latin America biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 69 Brazil biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 70 Mexico biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 71 Middle East & Africa (MEA) biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 72 South Africa biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 73 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
• Fig. 74 Strategy framework
• Fig. 75 Participant categorization